{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:05:27Z","timestamp":1791219927036,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1038\/6543","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:34:58Z","timestamp":1027658098000},"page":"320-326","source":"Crossref","is-referenced-by-count":490,"title":["Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy"],"prefix":"10.1038","volume":"5","author":[{"given":"Cornel","family":"Badorff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Lamphear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann E.","family":"Martone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Rhoads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk U.","family":"Knowlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm0399_320_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0735-1097(92)90094-4","volume":"20","author":"DD Schocken","year":"1992","unstructured":"Schocken, D.D., Arrieta, M.I., Leaverton, P.E. & Ross, E. A. Prevalence and mortality rate of congestive heart failure in the United States. J. Am. Coll. Cardiol. 20, 301\u2013 306 (1992).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnm0399_320_CR2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1161\/01.CIR.95.4.766","volume":"95","author":"JN Cohn","year":"1997","unstructured":"Cohn, J.N. et al. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 95, 766\u2013770 (1997).","journal-title":"Circulation"},{"key":"BFnm0399_320_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1365-2796.1996.461800000.x","volume":"239","author":"HJ Dargie","year":"1996","unstructured":"Dargie, H.J., McMurray, J.J. & McDonagh, T.A. Heart failure\u2014implications of the true size of the problem. J. Intern. Med. 239, 309 \u2013315 (1996).","journal-title":"J. Intern. Med."},{"key":"BFnm0399_320_CR4","first-page":"31","volume":"223","author":"C Baboonian","year":"1997","unstructured":"Baboonian, C., Davies, M.J., Booth, J.C. & McKenna, W.J. Coxsackie B viruses and human heart disease. Curr. Top. Microbiol. Immunol. 223, 31\u201352 ( 1997).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFnm0399_320_CR5","doi-asserted-by":"publisher","first-page":"99A","DOI":"10.1016\/0735-1097(93)90470-L","volume":"22","author":"MJ Sole","year":"1993","unstructured":"Sole, M.J. & Liu, P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J. Am. Coll. Cardiol. 22, 99A\u2013105A (1993).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnm0399_320_CR6","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJM199710093371511","volume":"337","author":"JM Leiden","year":"1997","unstructured":"Leiden, J.M. The genetics of dilated cardiomyopathy\u2013emerging clues to the puzzle. N. Engl. J. Med. 337, 1080\u2013 1081 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0399_320_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0955-0674(98)80096-3","volume":"10","author":"JA Towbin","year":"1998","unstructured":"Towbin, J.A. The role of cytoskeletal proteins in cardiomyopathies. Curr. Opin. Cell Biol. 10, 131\u2013139 ( 1998).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnm0399_320_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1126\/science.3055295","volume":"242","author":"SB Malhotra","year":"1988","unstructured":"Malhotra, S. B. et al. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242, 755\u2013 759 (1988).","journal-title":"Science"},{"key":"BFnm0399_320_CR9","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/01.CIR.95.10.2344","volume":"95","author":"AH Beggs","year":"1997","unstructured":"Beggs, A.H. Dystrophinopathy, the expanding phenotype. Dystrophin abnormalities in X-linked dilated cardiomyopathy. Circulation 95, 2344\u20132347 (1997).","journal-title":"Circulation"},{"key":"BFnm0399_320_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM198705073161904","volume":"316","author":"BA Berko","year":"1987","unstructured":"Berko, B.A. & Swift, M. X-linked dilated cardiomyopathy. N. Engl. J. Med. 316, 1186\u201391 (1987).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0399_320_CR11","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1161\/01.CIR.87.6.1854","volume":"87","author":"JA Towbi","year":"1993","unstructured":"Towbi, J.A. et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy locus. Circulation 87, 1854\u20131865 ( 1993).","journal-title":"Circulation"},{"key":"BFnm0399_320_CR12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJM199309233291304","volume":"329","author":"F Muntoni","year":"1993","unstructured":"Muntoni, F. et al. Brief report: Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329, 921\u20135 ( 1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0399_320_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.280.5364.750","volume":"280","author":"TM Olson","year":"1998","unstructured":"Olson, T.M., Michels, V.V., Thibodeau, S.N., Tai, Y. S. & Keating, M.T. Actin mutations in dilated cardiomyopathy, an inheritable form of heart failure. Science 280, 750\u2013752 (1998).","journal-title":"Science"},{"key":"BFnm0399_320_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/01.CIR.95.1.17","volume":"95","author":"M Maeda","year":"1997","unstructured":"Maeda, M., Holder, E., Lowes, B., Valent, S. & Bies, R.D. Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 95, 17\u201320 (1997).","journal-title":"Circulation"},{"key":"BFnm0399_320_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJM199602083340604","volume":"334","author":"R Fadic","year":"1996","unstructured":"Fadic, R. et al. Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. N. Engl. J. Med. 334, 362\u20136 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0399_320_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/hmg\/6.4.601","volume":"6","author":"V Nigro","year":"1997","unstructured":"Nigro, V. et al. Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6, 601\u2013 607 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm0399_320_CR17","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","volume":"90","author":"RM Grady","year":"1997","unstructured":"Grady, R.M. et al. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90, 729\u2013738 (1997).","journal-title":"Cell"},{"key":"BFnm0399_320_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0092-8674(00)81878-4","volume":"88","author":"S Arber","year":"1997","unstructured":"Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393\u2013403 (1997).","journal-title":"Cell"},{"key":"BFnm0399_320_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/01.CIR.98.5.450","volume":"98","author":"R Wessely","year":"1998","unstructured":"Wessely, R., Henke, A., Zell, R., Kandolf, R. & Knowlton, K.U. Low level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: An approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98, 450\u2013457 (1998).","journal-title":"Circulation"},{"key":"BFnm0399_320_CR20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1172\/JCI1972","volume":"102","author":"R Wessely","year":"1998","unstructured":"Wessely, R. et al. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Invest. 102, 1444\u20131453 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnm0399_320_CR21","first-page":"477","volume-title":"Fundamental Virology","author":"RR Rueckert","year":"1996","unstructured":"Rueckert, R. R. in Fundamental Virology Vol. 3 (eds. Fields, B.N., Knipe, D.M. & Howley, P.M.) 477\u2013522 (Raven, New York, 1996)."},{"key":"BFnm0399_320_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1128\/MCB.18.1.334","volume":"18","author":"A Gradi","year":"1998","unstructured":"Gradi, A. et al. A novel functional human eukaryotic translation initiation factor 4G. Mol. Cell Biol. 18, 334\u2013 342 (1998).","journal-title":"Mol. Cell Biol."},{"key":"BFnm0399_320_CR23","doi-asserted-by":"crossref","first-page":"19200","DOI":"10.1016\/S0021-9258(19)36499-3","volume":"268","author":"BJ Lamphear","year":"1993","unstructured":"Lamphear, B.J. et al. Mapping of the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. J. Biol. Chem. 268, 19200\u2013 19203 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFnm0399_320_CR24","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/pro.5560051107","volume":"5","author":"N Blom","year":"1996","unstructured":"Blom, N., Hansen, J., Blaas, D. & Brunak, S. Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci. 5, 2203\u20132216 (1996).","journal-title":"Protein Sci."},{"key":"BFnm0399_320_CR25","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1074\/jbc.272.9.5783","volume":"272","author":"Z Sheng","year":"1997","unstructured":"Sheng, Z. et al. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J. Biol. Chem. 272, 5783\u20135791 ( 1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm0399_320_CR26","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1006\/bbrc.1993.1922","volume":"194","author":"M Setoguchi","year":"1993","unstructured":"Setoguchi, M. et al. Expression and localization of dystrophin in cultured neonatal rat cardiac myocytes. Biochem. Biophys. Res. Commun. 194, 1012\u20131018 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm0399_320_CR27","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1016\/S0021-9258(18)31565-5","volume":"266","author":"JM Ervasti","year":"1991","unstructured":"Ervasti, J.M., Kahl, S.D. & Campbell, K.P. Purification of dystrophin from skeletal muscle. J. Biol. Chem. 266, 9161\u20139165 (1991).","journal-title":"J. Biol. Chem."},{"key":"BFnm0399_320_CR28","first-page":"24","volume":"66","author":"LH Chow","year":"1992","unstructured":"Chow, L.H., Beisel, K.W. & McManus, B.M. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab. Invest. 66, 24\u201331 (1992).","journal-title":"Lab. Invest."},{"key":"BFnm0399_320_CR29","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.1128\/JVI.69.11.6720-6728.1995","volume":"69","author":"A Henke","year":"1995","unstructured":"Henke, A., Huber, S., Stelzner, A. & Whitton, J.L. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69, 6720\u20136728 ( 1995).","journal-title":"J. Virol."},{"key":"BFnm0399_320_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1083\/jcb.139.2.375","volume":"139","author":"V Straub","year":"1997","unstructured":"Straub, V., Rafael, J.A., Chamberlain, J.S. & Campbell, K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375\u2013 385 (1997).","journal-title":"J. Cell Biol."},{"key":"BFnm0399_320_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/345315a0","volume":"345","author":"JM Ervasti","year":"1990","unstructured":"Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M. G. & Campbell, K.P. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315\u20139 ( 1990).","journal-title":"Nature"},{"key":"BFnm0399_320_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00019052-199704000-00016","volume":"10","author":"V Straub","year":"1997","unstructured":"Straub, V. & Campbell, K.P. Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10, 168\u2013175 (1997).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnm0399_320_CR33","doi-asserted-by":"publisher","first-page":"28771","DOI":"10.1074\/jbc.272.45.28771","volume":"272","author":"IN Rybakova","year":"1997","unstructured":"Rybakova, I.N. & Ervasti, J.M. Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. J. Biol. Chem. 272, 28771\u201328778 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm0399_320_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/hmg\/7.4.589","volume":"7","author":"RG Roberts","year":"1998","unstructured":"Roberts, R.G. & Bobrow, M. Dystrophins in vertebrates and invertebrates. Hum. Mol. Genet. 7, 589\u2013 595 (1998).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm0399_320_CR35","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1016\/S0021-9258(19)39599-7","volume":"265","author":"M Koenig","year":"1990","unstructured":"Koenig, M. & Kunkel, L.M. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem. 265, 4560\u2013 4566 (1990).","journal-title":"J. Biol. Chem."},{"key":"BFnm0399_320_CR36","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/JVI.67.6.3507-3514.1993","volume":"67","author":"PH Chen","year":"1993","unstructured":"Chen, P.H., Ornelles, D.A. & Shenk, T. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J. Virol. 67, 3507 \u20133514 (1993).","journal-title":"J. Virol."},{"key":"BFnm0399_320_CR37","first-page":"221","volume":"142","author":"RL Shoeman","year":"1993","unstructured":"Shoeman, R.L. et al. Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. Am. J. Pathol. 142, 221\u2013 230 (1993).","journal-title":"Am. J. Pathol."},{"key":"BFnm0399_320_CR38","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1128\/JVI.70.11.7811-7818.1996","volume":"70","author":"KU Knowlton","year":"1996","unstructured":"Knowlton, K.U., Jeon, E.S., Berkley, N., Wessely, R. & Huber, S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of CVB3. J. Virol. 70 (11), 7811\u2013 7818 (1996).","journal-title":"J. Virol."},{"key":"BFnm0399_320_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/01.RES.75.1.156","volume":"75","author":"PL Schwimmbeck","year":"1994","unstructured":"Schwimmbeck, P.L., Badorff, C., Schultheiss, H.P. & Strauer, B.E. Transfer of human myocarditis into severe combined immunodeficiency mice. Circ. Res. 75, 156\u2013164 (1994).","journal-title":"Circ. Res."},{"key":"BFnm0399_320_CR40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1083\/jcb.95.3.763","volume":"95","author":"D Bader","year":"1982","unstructured":"Bader, D., Masaki, T. & Fischman, D.A. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95, 763\u2013770 ( 1982).","journal-title":"J. Cell Biol."},{"key":"BFnm0399_320_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-510X(89)90223-2","volume":"94","author":"LV Nicholson","year":"1989","unstructured":"Nicholson, L.V. et al. Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J. Neurol. Sci. 94, 125\u2013136 (1989).","journal-title":"J. Neurol. Sci."},{"key":"BFnm0399_320_CR42","doi-asserted-by":"publisher","first-page":"11117","DOI":"10.1021\/bi9805137","volume":"37","author":"GE Morris","year":"1998","unstructured":"Morris, G.E. et al. An epitope structure for the C-terminal domain of dystrophin and utrophin. Biochemistry 37, 11117\u2013 11127 (1998).","journal-title":"Biochemistry"},{"key":"BFnm0399_320_CR43","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI119464","volume":"99","author":"MJ Spencer","year":"1997","unstructured":"Spencer, M.J., Walsh, C.M., Dorshkind, K.A., Rodriguez, E.M. & Tidball, J.G. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J. Clin. Invest. 99, 2745\u20132751 ( 1997).","journal-title":"J. Clin. Invest."},{"key":"BFnm0399_320_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/viro.1997.8595","volume":"234","author":"W Sommergruber","year":"1997","unstructured":"Sommergruber, W. et al. Mutational analyses support a model for the HRV2 2A proteinase. Virology 234, 203\u2013214 (1997).","journal-title":"Virology"},{"key":"BFnm0399_320_CR45","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/JVI.72.7.5654-5660.1998","volume":"72","author":"EM Schwarz","year":"1998","unstructured":"Schwarz, E.M. et al. NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. J. Virol. 72, 5654\u2013 5660 (1998).","journal-title":"J. Virol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0399_320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0399_320","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0399_320.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:12:57Z","timestamp":1684433577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0399_320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["BFnm0399_320"],"URL":"https:\/\/doi.org\/10.1038\/6543","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}